Skip to content
2000
Volume 11, Issue 2
  • ISSN: 1573-4099
  • E-ISSN: 1875-6697

Abstract

A 3D-QSAR selectivity analysis of 53 adamantyl heteroaryl urea derivatives active against M. tuberculosis is reported. These analogs inhibit Mycobacterial Membrane Protein Large 3 (MmpL3), a proposed transporter for cell wall mycolic acids. However, these analogs also exhibit affinity towards human soluble epoxide hydrolase (sEH) enzyme, making them pharmacologically undesirable. Thus, COMFA and CoMSIA selective studies viz ligand and receptor-based alignment has been described to evaluate key pharmacophoric structural features that may possibly play a crucial role for selective inhibition. This hypothesis was experimentally validated and successfully tested on four novel adamantyl urea based derivatives with known biological activity. Therefore, this approach may pave way to novel specific inhibitors in tuberculosis drug discovery process.

Loading

Article metrics loading...

/content/journals/cad/10.2174/1573409911666150803154114
2015-06-01
2025-05-06
Loading full text...

Full text loading...

/content/journals/cad/10.2174/1573409911666150803154114
Loading

  • Article Type:
    Research Article
Keyword(s): CoMFA; CoMSIA; docking; homology modelling; human sEH; MmpL3; tuberculosis
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test